anti-PD-L1 immunotherapy
2 abstracts
Abstract
Alisertib in patients with extensive-stage small-cell lung cancer: The phase 2 ALISCA-Lung1 study.Org: Puma Biotechnology Inc.,
Abstract
The incidence of thyroid-related adverse events in solid tumors receiving immune checkpoint blockade with curative intent: A meta-analysis.Org: Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, Mount Sinai Beth Israel, Yokohama City University Hospital, The Tisch Cancer Institute,